Literature DB >> 6499840

Antibiotic sensitivity of "Campylobacter pylori".

G Kasper, N Dickgiesser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6499840     DOI： 10.1007/bf02017370

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  5 in total

1.  Antibody to spiral organisms on gastric mucosa.

Authors:  J Eldridge; A M Lessells; D M Jones
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321

2.  Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

Authors:  B J Marshall; J R Warren
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

3.  Campylobacter-like organisms in the stomach of patients and healthy individuals.

Authors: 
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

4.  Unidentified curved bacilli on gastric epithelium in active chronic gastritis.

Authors:  J R Warren; B Marshall
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

5.  Spiral organisms in endoscopic biopsies of the human stomach.

Authors:  T P Rollason; J Stone; J M Rhodes
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411
  5 in total
  7 in total

1.  Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.

Authors:  C A McNulty; J Dent; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

2.  Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents.

Authors:  T Lambert; F Mégraud; G Gerbaud; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

3.  Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, roxithromycin [RU 28965], and CP 62,993) and rifampin.

Authors:  S Czinn; H Carr; S Aronoff
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

4.  Characterization of "Campylobacter pyloridis" by culture, enzymatic profile, and protein content.

Authors:  F Megraud; F Bonnet; M Garnier; H Lamouliatte
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

5.  Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents.

Authors:  D L Shungu; D R Nalin; R H Gilman; H H Gadebusch; A T Cerami; C Gill; B Weissberger
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

6.  In vitro activity of metronidazole against Helicobacter pylori as determined by agar dilution and agar diffusion.

Authors:  C C Knapp; M D Ludwig; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

7.  Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents.

Authors:  Y Glupczynski; M Delmee; C Bruck; M Labbe; V Avesani; A Burette
Journal:  Eur J Epidemiol       Date:  1988-06       Impact factor: 8.082
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.